Chemical activators of OR6C70 include a variety of compounds that initiate intracellular signaling cascades, leading to the functional activation of this protein. Forskolin, a well-known adenylyl cyclase activator, elevates intracellular levels of cAMP, a secondary messenger that activates protein kinase A (PKA). PKA, in turn, can activate OR6C70 by phosphorylating specific sites on the protein, leading to a conformational change that enhances its activity. Similarly, isoproterenol, a beta-adrenergic agonist, also raises cAMP levels, subsequently activating PKA, which then can phosphorylate and activate OR6C70. Adenosine, through its action on adenosine receptors, follows a similar path by increasing cAMP and activating PKA, which is known to phosphorylate various proteins, thereby including OR6C70 among those that can be activated by this kinase-mediated pathway.
Histamine and pilocarpine, by binding to their respective receptors, set off a series of events that elevate intracellular calcium levels or secondary messengers like cAMP. This increase in calcium can activate a range of calcium-dependent kinases capable of phosphorylating OR6C70, leading to its activation. Cinacalcet's activation of the calcium-sensing receptor (CaSR) also results in intracellular calcium increases that activate downstream kinases, which can then phosphorylate OR6C70. TRP channel activators such as capsaicin, icilin, and menthol alter calcium signaling within the cell, providing further opportunities for kinase-mediated activation of OR6C70. Lastly, vardenafil and sildenafil maintain elevated levels of cGMP by inhibiting phosphodiesterase type 5, which leads to the activation of protein kinase G (PKG). PKG can phosphorylate substrates including OR6C70, which would result in the activation of this protein through direct phosphorylation. These chemicals represent a variety of mechanisms by which OR6C70 can be activated through intracellular signaling pathways involving phosphorylation by different kinases.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that elevates intracellular cAMP, subsequently activating PKA. PKA can phosphorylate OR6C70, leading to its activation. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Activates TRPV1 channels, which can trigger downstream signaling pathways, including calcium influx and kinase activation, potentially resulting in the activation of OR6C70. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Binds to and activates G protein-coupled receptors, potentially causing a conformational change that could activate OR6C70. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Activates adenosine receptors which can activate adenylate cyclase, leading to increased cAMP and activation of PKA. PKA can then activate OR6C70 through phosphorylation. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Binds to histamine receptors, initiating signaling cascades involving cAMP and PKA, which may activate OR6C70 through phosphorylation. | ||||||
Pilocarpine | 92-13-7 | sc-479256 | 100 mg | $255.00 | 1 | |
Muscarinic acetylcholine receptor agonist that increases intracellular calcium, which can activate kinases that phosphorylate and activate OR6C70. | ||||||
Icilin | 36945-98-9 | sc-201557 sc-201557A | 10 mg 50 mg | $91.00 $257.00 | 9 | |
Agonist for TRPM8 channels, altering calcium signaling, which can activate kinases that phosphorylate and activate OR6C70. | ||||||
(±)-Menthol | 89-78-1 | sc-250299 sc-250299A | 100 g 250 g | $39.00 $68.00 | ||
Activates TRPM8 channels leading to changes in calcium signaling pathways, potentially activating kinases that phosphorylate and activate OR6C70. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Inhibits phosphodiesterase type 5, preventing cGMP breakdown, which can enhance PKG activation. PKG can then phosphorylate and potentially activate OR6C70. | ||||||